Patent US4241076A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4241076A Expired / Lapsed US ⏱️ 0.0 years remaining

Halogenated substituted mercaptoacylamino acids

Assignee: ER Squibb and Sons LLC
•
Filing: 1979-05-09
•
Granted: 1980-12-23
•
Expires: 1999-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New halogen substituted mercaptoacylamino acids which have the general formula ##STR1## and basic salts thereof are useful as hypotensive agents.

Inventors

  • 👤 Miguel A. Ondetti
  • 👤 Peter W. Sprague

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 10:01
CPC Classifications
C; C07; C07C; C07C53/00; C07C53/15; C07C53/19; C07C53/21; C07D; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/16; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/60

Claims Analysis

Total Claims: 41
Claim 1
Independent Claim 122 words
A compound of the formula ##STR18## wherein R is hydrogen, lower alkanoyl, ##STR19## m is zero, one, or two; R 1 is hydrogen or lower alkyl; R 2 , R 5 and R 6 each is hydrogen or halogen; R 3 is hydrogen, lower alkyl, halogen or trifluoromethyl provided that when n is zero R 3 is other than halogen; R 4 is hydrogen, lower alkyl or trifluoromethyl; and n is 0 or 1; with the provisos that at least one of R 2 , R 3 , R 4 , R 5 and R 6 as defined above is a halogen and that only R 2 and R 5 can both be halogen in the same compound; and basic salts thereof.
Claim 2
Dependent Claim 122 words
A compound of the formula ##STR18## wherein R is hydrogen, lower alkanoyl, ##STR19## m is zero, one, or two; R 1 is hydrogen or lower alkyl; R 2 , R 5 and R 6 each is hydrogen or halogen; R 3 is hydrogen, lower alkyl, halogen or trifluoromethyl provided that when n is zero R 3 is other than halogen; R 4 is hydrogen, lower alkyl or trifluoromethyl; and n is 0 or 1; with the provisos that at least one of R 2 , R 3 , R 4 , R 5 and R 6 as defined above is a halogen and that only R 2 and R 5 can both be halogen in the same compound; and basic salts thereof.
Claim 3
Dependent Claim 68 words
A compound of the formula ##STR20## wherein R is hydrogen, lower alkanoyl or ##STR21## R 1 is hydrogen or lower alkyl; R 2 and R 5 are each the same halogen or one is halogen and the other is hydrogen; R 3 and R 4 each is hydrogen or trifluoromethyl, one being hydrogen and the other trifluoromethyl; and n is 0 or 1; and physiologically acceptable salts thereof.
Claim 4
Dependent Claim 68 words
A compound of the formula ##STR20## wherein R is hydrogen, lower alkanoyl or ##STR21## R 1 is hydrogen or lower alkyl; R 2 and R 5 are each the same halogen or one is halogen and the other is hydrogen; R 3 and R 4 each is hydrogen or trifluoromethyl, one being hydrogen and the other trifluoromethyl; and n is 0 or 1; and physiologically acceptable salts thereof.
Claim 5
Dependent Claim 17 words
The compound of claim 2 wherein the proline as represented by the asterisk is in the L-configuration.
Claim 6
Dependent Claim 14 words
The compound of claim 3 wherein R 2 and R 5 are both fluorine.
Claim 7
Dependent Claim 14 words
The compound of claim 4 wherein R is acetyl and R 1 is hydrogen.
Claim 8
Dependent Claim 13 words
The compound of claim 4 wherein R and R 1 are both hydrogen.
Claim 9
Dependent Claim 18 words
The compound of claim 6 wherein n is one; R 3 is trifluoromethyl; and R 4 is hydrogen.
Claim 10
Dependent Claim 18 words
The compound of claim 6 wherein n is one; R 3 is hydrogen; and R 4 is trifluoromethyl.
Claim 11
Dependent Claim 15 words
The compound of claim 3 wherein R 2 is fluorine and R 5 is hydrogen.
Claim 12
Dependent Claim 14 words
The compound of claim 9 wherein R is acetyl and R 1 is hydrogen.
Claim 13
Dependent Claim 13 words
The compound of claim 9 wherein R and R 1 are both hydrogen.
Claim 14
Dependent Claim 15 words
The compound of claim 3 wherein R 2 is chlorine and R 5 is hydrogen.
Claim 15
Dependent Claim 14 words
The compound of claim 12 wherein R is acetyl and R 1 is hydrogen.
Claim 16
Dependent Claim 13 words
The compound of claim 12 wherein R and R 1 are both hydrogen.
Claim 17
Dependent Claim 114 words
A compound of the formula ##STR22## wherein R is hydrogen, lower alkanoyl, or ##STR23## R 1 is hydrogen or lower alkyl; R 2 and R 5 each is hydrogen or halogen provided that when R 2 and R 5 are both halogen the two halogens are the same; R 3 is hydrogen, halogen, or lower alkyl provided that R 3 is halogen when R 2 and R 5 are both hydrogen and R 3 is other than halogen when either or both R 2 and R 5 is halogen; R 4 is hydrogen; and n is zero or one provided that n is one when R 3 is halogen; and physiologically acceptable salts thereof.
Claim 18
Dependent Claim 114 words
A compound of the formula ##STR22## wherein R is hydrogen, lower alkanoyl, or ##STR23## R 1 is hydrogen or lower alkyl; R 2 and R 5 each is hydrogen or halogen provided that when R 2 and R 5 are both halogen the two halogens are the same; R 3 is hydrogen, halogen, or lower alkyl provided that R 3 is halogen when R 2 and R 5 are both hydrogen and R 3 is other than halogen when either or both R 2 and R 5 is halogen; R 4 is hydrogen; and n is zero or one provided that n is one when R 3 is halogen; and physiologically acceptable salts thereof.
Claim 19
Dependent Claim 17 words
The compound of claim 15 wherein the proline as represented by the asterisk is in the L-configuration.
Claim 20
Dependent Claim 22 words
The compound of claim 16 wherein R 2 and R 5 are both hydrogen; n is one; and R 3 is halogen.
Claim 21
Dependent Claim 12 words
The compound of claim 17 wherein R 3 is chlorine or bromine.
Claim 22
Dependent Claim 18 words
The compound of claim 18 wherein R 3 is chlorine; R is acetyl; and R 1 is hydrogen.
Claim 23
Dependent Claim 18 words
The compound of claim 18 wherein R 3 is bromine; R is acetyl; and R 1 is hydrogen.
Claim 24
Dependent Claim 21 words
The compound of claim 16 wherein R 2 and R 5 are both fluorine; and R 3 is hydrogen or methyl.
Claim 25
Dependent Claim 13 words
The compound of claim 21 wherein R and R 1 are both hydrogen.
Claim 26
Dependent Claim 14 words
The compound of claim 22 wherein n is one and R 3 is methyl.
Claim 27
Dependent Claim 6 words
The compound of claim 23, 4,4-difluoro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.
Claim 28
Dependent Claim 21 words
The compound of claim 16 wherein R 2 and R 5 are both chlorine; and R 3 is hydrogen or methyl.
Claim 29
Dependent Claim 13 words
The compound of claim 25 wherein R and R 1 are both hydrogen.
Claim 30
Dependent Claim 14 words
The compound of claim 26 wherein n is one and R 3 is methyl.
Claim 31
Dependent Claim 21 words
The compound of claim 16 wherein R 2 is fluorine; R 5 is hydrogen; and R 3 is hydrogen or methyl.
Claim 32
Dependent Claim 13 words
The compound of claim 28 wherein R and R 1 are both hydrogen.
Claim 33
Dependent Claim 14 words
The compound of claim 29 wherein n is one and R 3 is methyl.
Claim 34
Dependent Claim 6 words
The compound of claim 30, cis-4-fluoro-1-(D-3-mercapto-2-methylpropanoyl)-2-proline.
Claim 35
Dependent Claim 6 words
The compound of claim 30, trans-4-fluoro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.
Claim 36
Dependent Claim 21 words
The compound of claim 16 wherein R 2 is chlorine; R 5 is hydrogen; and R 3 is hydrogen or methyl.
Claim 37
Dependent Claim 13 words
The compound of claim 33 wherein R and R 1 are both hydrogen.
Claim 38
Dependent Claim 14 words
The compound of claim 34 wherein n is one and R 3 is methyl.
Claim 39
Dependent Claim 6 words
The compound of claim 35, cis-4-chloro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.
Claim 40
Dependent Claim 38 words
A method for alleviating hypertension in a hypertensive mammal which comprises administering to said mammal an effective amount of a composition comprising a compound of claim 1 or physiologically acceptable salt thereof and a pharmaceutically acceptable vehicle therefor.
Claim 41
Dependent Claim 34 words
A composition useful for alleviating hypertension in a hypertensive mammal comprising from about 10 to 500 mg. of a compound of claim 1 or physiologically acceptable salt thereof and a pharmaceutically acceptable carrier therefor.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-12-23 1984-06-23 1984-12-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-12-23 1988-06-23 1988-12-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-12-23 1992-06-23 1992-12-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag